Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes
June 9th, 2023
2.6K views
In this study, we developed a low-cost surface-enhanced Raman scattering (SERS)-based fingerprint nanoprobe with favorable biocompatibility to show label-free live cell bioimaging and detect two bacterial strains, showing in detail how to get SERS spectra of living cells in a non-destructive method.
Overview
This study presents a low-cost surface-enhanced Raman scattering (SERS)-based fingerprint nanoprobe designed for label-free live cell bioimaging. The probe demonstrates favorable biocompatibility and the ability to detect two bacterial strains, providing detailed SERS spectra of living cells in a non-destructive manner.
Key Study Components
Area of Science
- Biophysics
- Cell Biology
- Analytical Chemistry
Background
- Surface-enhanced Raman scattering (SERS) is a powerful technique for molecular detection.
- Label-free imaging techniques are crucial for studying live cells without altering their state.
- Challenges exist in obtaining clear Raman signals due to background interference from other chemicals.
- Recent advancements focus on improving sensitivity and reproducibility in molecular analysis.
Purpose of Study
- To develop a cost-effective SERS-based nanoprobe for live cell imaging.
- To enable the detection of bacterial strains using molecular fingerprinting.
- To facilitate non-destructive analysis of living cells.
Methods Used
- Development of a SERS-based fingerprint nanoprobe.
- Label-free imaging of live cells.
- Principal component analysis of single living cells.
- Comparison of SERS signals with traditional frozen detection methods.
Main Results
- The nanoprobe successfully detected two bacterial strains.
- High surface sensitivity was achieved for live cell analysis.
- Non-destructive methods provided intrinsic chemical information at the single-cell level.
- Principal component analysis revealed significant molecular details of living cells.
Conclusions
- The developed SERS-based nanoprobe is a promising tool for live cell bioimaging.
- It offers a non-invasive approach to study cellular processes.
- This technology can enhance the detection and analysis of multiple analytes in biological samples.
Frequently Asked Questions
What is SERS?
SERS stands for surface-enhanced Raman scattering, a technique that enhances Raman signals for molecular detection.
How does the nanoprobe work?
The nanoprobe utilizes SERS to provide molecular fingerprint information from live cells without labeling.
What are the advantages of label-free imaging?
Label-free imaging allows for the observation of live cells in their natural state without introducing external markers.
What types of bacteria were detected in the study?
The study successfully detected two bacterial strains using the developed nanoprobe.
What is principal component analysis?
Principal component analysis is a statistical method used to reduce data dimensionality and identify patterns.
Can this technology be applied to other types of cells?
Yes, the SERS-based nanoprobe can potentially be adapted for various cell types and applications in biological research.
Executive Industry Relevance
Label-free SERS bioanalysis using Au@carbon dot nanoprobes enables high-sensitivity molecular fingerprinting of live cells and bacteria, supporting early-stage target validation and mechanistic de-risking. This approach enhances predictive confidence in cellular and microbial profiling, facilitating risk-adjusted decisions in discovery and translational research pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct molecular fingerprinting of cellular and microbial components for hypothesis interrogation.
- Supports functional target validation by distinguishing cellular heterogeneity at the single-cell level.
- Facilitates mechanistic de-risking through label-free detection of intrinsic chemical profiles.
- Improves predictive confidence for portfolio triage by providing reproducible, quantitative SERS outputs.
Screening & Assay Development
- Prepares validated SERS-active biological systems for downstream screening workflows.
- Delivers standardized, reproducible, and quantitative Raman spectra for assay development.
- Enables high-sensitivity detection of analytes at nanomolar concentrations, supporting robust screening readiness.
- Allows platform reuse for diverse cell and bacterial profiling applications.
Translational & Preclinical Research
- Aligns with disease-relevant system analysis by enabling label-free profiling of cancer cells and bacteria.
- Supports translational biomarker discovery through principal component analysis of SERS spectra.
- Provides continuity from discovery to preclinical validation by maintaining native cellular conditions during analysis.
- Reduces biological risk by enabling non-destructive, real-time chemical profiling.
Pipeline & Workflow Integration
This SERS-based nanoprobe method integrates from early discovery through lead identification and preclinical research, supporting hypothesis testing and quantitative analytics across the pipeline.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification via molecular fingerprinting of live cells and bacteria.
- Screening: Provides reproducible, quantitative SERS outputs for assay standardization and compound evaluation.
- Analytics: Enables principal component analysis for robust comparison of cellular and microbial spectra.
- Translational Research: Maintains disease relevance and biomarker alignment through label-free, in situ profiling.
- Enterprise Reuse: Offers a scalable, reusable platform for diverse bioanalytical applications in R&D.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Delivers standardized, reproducible, and scalable SERS bioanalysis workflows.
- Strategic Value: Supports informed go/no-go decisions and capital efficiency by reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery assets.
Implementation Considerations
- Requires expertise in SERS instrumentation and spectral data analysis.
- Needs access to Raman spectrometers and compatible imaging infrastructure.
- Demands cross-team standardization of sample preparation and spectral acquisition protocols.
- Adaptable to various cell and bacterial models with minimal cytotoxicity observed.
- Long-term nanoprobe stability and signal decay should be monitored for consistent performance.
Biopharma FAQs
Why does null hypothesis testing matter for SERS-based target validation?
Null hypothesis testing using SERS spectra enables objective differentiation of cellular or microbial components, supporting robust target validation. This statistical rigor reduces false positives and increases confidence in early discovery decisions.
How does independent variable isolation fit SERS nanoprobe discovery workflows?
Isolating variables such as cell type or analyte concentration allows precise attribution of SERS spectral changes, clarifying mechanistic pathways and supporting reproducible discovery-stage findings.
What do quantitative dependent variable measurements enable in SERS bioanalysis?
Quantitative SERS measurements provide high-sensitivity detection of molecular fingerprints, enabling comparison across conditions and supporting data-driven advancement decisions in R&D pipelines.
Why are replication requirements critical for cross-functional SERS collaboration?
Replication of SERS spectra across multiple points and timeframes ensures reproducibility, facilitating reliable data sharing and alignment between discovery, screening, and translational teams.
What statistical analysis capabilities are required before SERS implementation?
Robust statistical tools such as principal component analysis are essential for interpreting complex SERS datasets, enabling pattern recognition and supporting confident decision-making in biopharma R&D.
